Cardiovascular complications secondary to Graves' disease: a prospective study from Ukraine

Iryna Tsymbaliuk1, Dmytro Unukovych2, Nataliia Shvets1

  • 1Department of Therapy, Shupyk National Medical Academy of Postgraduate Education, 04112 Kiev, Ukraine; Department of Functional Diagnostic, Kyiv City Teaching Endocrinological Center, 01034 Kiev, Ukraine.

Plos One
|March 25, 2015
PubMed

Insights

Restoring euthyroid state in Graves' disease patients significantly reduces cardiovascular issues and improves quality of life. This study highlights the positive impact of thyroid normalization on thyrotoxic heart disease patients.

Area of Science:

  • Cardiology
  • Endocrinology
  • Quality of Life Research

Background:

  • Graves' disease (GD) is a leading cause of hyperthyroidism.
  • Hyperthyroidism can lead to thyrotoxic heart disease (THD).

Purpose of the Study:

  • To assess cardiovascular complications in patients with THD secondary to GD.
  • To evaluate health-related quality of life (HRQoL) in these patients.

Main Methods:

  • Clinical assessment of 61 patients with THD secondary to GD before and after achieving a euthyroid state.
  • HRQoL assessment using the EQ-5D-5L questionnaire in 30 patients.
  • Statistical analysis to determine the impact of treatment on cardiovascular parameters and HRQoL.

Main Results:

  • Significant reductions in resting heart rate, blood pressure, atrial fibrillation, congestive heart failure, and thyrotoxic cardiomyopathy after treatment (p<0.01).
  • Anti-TSH receptor antibodies identified as predictors of left ventricular geometry changes (p=0.02).
  • HRQoL domains and self-rated health significantly improved (p<0.001).

Conclusions:

  • Achieving a euthyroid state in GD patients effectively eliminates cardiovascular disorders.
  • Treatment of THD secondary to GD substantially enhances patient HRQoL.
  • This study provides novel insights into HRQoL among Ukrainian patients with THD secondary to GD.
Abstract

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...